GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $36.78 $43.42 Friday, 19th Apr 2024 CLDX stock ended at $37.98. This is 1.43% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.58% from a day low at $36.78 to a day high of $38.47.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
2021-09-17 $55.06 $56.11 $52.68 $54.39 1 930 721
2021-09-16 $53.22 $53.99 $52.20 $53.28 536 747
2021-09-15 $53.22 $54.33 $52.84 $53.21 374 483
2021-09-14 $54.38 $55.31 $53.18 $53.30 406 292
2021-09-13 $54.76 $55.05 $51.53 $54.06 309 547
2021-09-10 $55.16 $56.17 $54.44 $54.52 599 488
2021-09-09 $55.14 $56.14 $53.76 $53.76 466 655
2021-09-08 $55.17 $56.09 $55.02 $55.19 322 491
2021-09-07 $54.23 $55.57 $54.13 $55.19 470 413
2021-09-03 $54.49 $54.71 $53.62 $54.23 896 443
2021-09-02 $54.36 $54.54 $53.00 $54.41 342 591
2021-09-01 $52.46 $54.03 $51.83 $53.83 588 807
2021-08-31 $51.97 $53.13 $51.82 $52.65 792 381
2021-08-30 $51.49 $52.11 $51.04 $51.80 297 457
2021-08-27 $50.50 $51.85 $50.18 $50.99 516 512
2021-08-26 $50.27 $51.89 $49.65 $50.24 511 945
2021-08-25 $49.19 $50.59 $48.73 $50.01 719 246
2021-08-24 $49.00 $50.03 $48.12 $49.08 391 970
2021-08-23 $48.35 $49.12 $48.02 $48.96 676 513
2021-08-20 $45.29 $48.21 $45.29 $47.55 641 929
2021-08-19 $44.20 $46.68 $44.20 $45.60 700 827
2021-08-18 $45.60 $46.30 $43.96 $44.66 370 329
2021-08-17 $42.42 $45.51 $41.98 $45.47 427 162
2021-08-16 $43.53 $43.53 $42.28 $43.07 428 151
2021-08-13 $45.79 $45.79 $43.65 $43.72 580 923
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT